Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025BloodOpen Access

Impact of induction regimen and co-mutations on outcomes in AML with myelodysplasia-related changes

View Full Paper
Ask AI
Bookmark
Share

Authors

RSRafeh SafdarJHJonah HeidelCIChaitanya Iragavarapu

Discussion

Loading...

Member takes

Overview

Retrospective analysis reveals treatment responses vary in AML-MRC, highlighting the role of epigenetic mutations and therapy type.

Key Points

  • To evaluate the effects of different induction regimens and co-mutations on outcomes in AML with myelodysplasia-related changes.
  • Single-institution retrospective study
  • Reviewed medical records of AML-MRC patients
  • Analyzed treatment responses and survival outcomes by induction regimens and mutations
  • Performed propensity score matching and statistical analyses using R.
  • 60% of patients achieved complete remission or CR with incomplete recovery after therapy
  • CLIA-Ven showed the highest remission rates compared to other regimens
  • Allogeneic transplant improved relapse-free and overall survival significantly
  • No significant differences in outcomes were found among induction regimens after adjustment for confounding factors.

Cite This Study

Safdar et al. (2025) studied this question.

synapsesocial.com/papers/69362f744fa91c937236e294https://doi.org/10.1182/blood-2025-7034
View Full Paper
Ask AI
Bookmark
Share